Profile Image
Nancy Zeleznik-Le Photo
Name
Nancy Zeleznik-Le
Degree
Ph.D.
Rank
Professor
Primary Department
Cancer Biology
Publications
Schmidt, CR; Achille, NJ; Kuntimaddi, A; Boulton, AM; Leach, BI; Zhang, S; Zeleznik-Le, NJ; Bushweller, JH BCOR Binding to MLL-AF9 Is Essential for Leukemia via Altered EYA1, SIX, and MYC Activity. Blood cancer discovery ; 1 2
Perez, C; Prajapati, K; Burke, B; Plaza-Rojas, L; Zeleznik-Le, NJ; Guevara-Patino, JA NKG2D signaling certifies effector CD8 T cells for memory formation. Journal for immunotherapy of cancer ; 7 1
Perez C, Prajapati K, Burke B, Plaza-Rojas L, Zeleznik-Le NJ, Guevara-Patino JA. NKG2D signaling certifies effector CD8 T cells for memory formation. Journal for immunotherapy of cancer ; 7 1 48
Li, Z; Huang, H; Chen, P; He, M; Li, Y; Arnovitz, S; Jiang, X; He, C; Hyjek, E; Zhang, J; Zhang, Z; Elkahloun, A; Cao, D; Shen, C; Wunderlich, M; Wang, Y; Neilly, MB; Jin, J; Wei, M; Lu, J; Valk, PJM; Delwel, R; Lowenberg, B; Le Beau, MM; Vardiman, J; Mulloy, JC; Zeleznik-Le, NJ; Liu, PP; Zhang, J; Chen, J Publisher Correction: miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia. Nature communications ; 9
Velu, CS; Chaubey, A; Phelan, JD; Horman, SR; Wunderlich, M; Guzman, ML; Jegga, AG; Zeleznik-Le, NJ; Chen, J; Mulloy, JC; Cancelas, JA; Jordan, CT; Aronow, BJ; Marcucci, G; Bhat, B; Gebelein, B; Grimes, HL Therapeutic antagonists of microRNAs deplete leukemia-initiating cell activity. The Journal of clinical investigation ; 124 1
Zeleznik-Le, NJ; Testa, JR In memoriam: Janet D. Rowley, MD (April 5, 1925-December 17, 2013). Cancer genetics ; 207 1-2
Risner, LE; Kuntimaddi, A; Lokken, AA; Achille, NJ; Birch, NW; Schoenfelt, K; Bushweller, JH; Zeleznik-Le, NJ Functional specificity of CpG DNA-binding CXXC domains in mixed lineage leukemia. The Journal of biological chemistry ; 288 41